Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Mirum Pharmaceuticals (MIRM) Debt Ratio: 2020-2023

Historic Debt Ratio for Mirum Pharmaceuticals (MIRM) over the last 2 years, with Mar 2023 value amounting to 0.00.

  • Mirum Pharmaceuticals' Debt Ratio fell 54.46% to 0.00 in Q1 2023 from the same period last year, while for Mar 2023 it was 0.00, marking a year-over-year decrease of 54.46%. This contributed to the annual value of 0.00 for FY2022, which is 54.41% down from last year.
  • Per Mirum Pharmaceuticals' latest filing, its Debt Ratio stood at 0.00 for Q1 2023, which was up 5.81% from 0.00 recorded in Q4 2022.
  • Over the past 5 years, Mirum Pharmaceuticals' Debt Ratio peaked at 0.01 during Q2 2021, and registered a low of 0.00 during Q4 2022.
  • In the last 3 years, Mirum Pharmaceuticals' Debt Ratio had a median value of 0.00 in 2022 and averaged 0.01.
  • As far as peak fluctuations go, Mirum Pharmaceuticals' Debt Ratio soared by 71.48% in 2022, and later tumbled by 54.46% in 2023.
  • Mirum Pharmaceuticals' Debt Ratio (Quarterly) stood at 0.01 in 2020, then climbed by 29.09% to 0.01 in 2021, then slumped by 54.41% to 0.00 in 2022, then plummeted by 54.46% to 0.00 in 2023.
  • Its Debt Ratio stands at 0.00 for Q1 2023, versus 0.00 for Q4 2022 and 0.00 for Q3 2022.